Anticancer Drug Development Guide

Preclinical Screening, Clinical Trials, and Approval

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Anticancer Drug Development Guide by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781592597390
Publisher: Humana Press Publication: February 1, 2004
Imprint: Humana Language: English
Author:
ISBN: 9781592597390
Publisher: Humana Press
Publication: February 1, 2004
Imprint: Humana
Language: English

This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors.

More books from Humana Press

Cover of the book Studies on Women's Health by
Cover of the book Benzodiazepines and GHB by
Cover of the book Diseases of the Thyroid by
Cover of the book Essentials of Sleep Medicine by
Cover of the book Drug Discovery and Development by
Cover of the book Infectious Diseases and Arthropods by
Cover of the book A Clinical Guide to Occupational and Environmental Lung Diseases by
Cover of the book Essentials of Apoptosis by
Cover of the book Translational Cardiology by
Cover of the book Alternative Medicine and Ethics by
Cover of the book COX-2 Blockade in Cancer Prevention and Therapy by
Cover of the book Shoulder Dystocia and Birth Injury by
Cover of the book Nuclear Reprogramming and Stem Cells by
Cover of the book Endocrine Oncology by
Cover of the book Cytokine Knockouts by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy